Invention Grant
- Patent Title: Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
-
Application No.: US17392578Application Date: 2021-08-03
-
Publication No.: US11857561B2Publication Date: 2024-01-02
- Inventor: Robert Shalwitz
- Applicant: Invirsa, Inc.
- Applicant Address: US OH Columbus
- Assignee: Invirsa, Inc.
- Current Assignee: Invirsa, Inc.
- Current Assignee Address: US OH Columbus
- Agency: Jones Day
- The original application number of the division: US15999269
- Main IPC: A61K31/7076
- IPC: A61K31/7076 ; A61P27/02 ; A61P35/00 ; A61K9/00 ; A61K31/522 ; A61K31/675 ; A61K33/24 ; A61K33/30 ; A61K33/34 ; C07H19/207
Abstract:
The present invention is directed to methods for the use of 5′-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing adenovirus-related diseases or conditions, eye disorders, cancer, or diseases or conditions caused by infection, inflammation, or physical, chemical, thermal, or radiation injuries.
Public/Granted literature
- US20220054522A1 METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR) Public/Granted day:2022-02-24
Information query
IPC分类:
